You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

CLINICAL TRIALS PROFILE FOR DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01606007 ↗ Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes Completed AstraZeneca Phase 3 2012-07-01 The purpose of this study is to learn if a combination of BMS-477118 (Saxagliptin) and BMS -512148 (Dapagliflozin) added to Metformin can improve (decrease) Glycosylated Hemoglobin (Hemoglobin A1c) in patients with type 2 diabetes after 24 weeks of treatment. The safety of this treatment will also be studied.
NCT01619059 ↗ Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes Completed AstraZeneca Phase 3 2012-06-01 The purpose of this study is to learn if BMS-477118 (Saxagliptin) as part of a triple combination therapy can improve (decrease) hemoglobin A1c in patients with type 2 diabetes after 24 weeks of treatment compared to a 2 drug oral antidiabetic therapy. The safety of this treatment will also be studied.
NCT01646320 ↗ Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes Completed AstraZeneca Phase 3 2012-09-01 The purpose of this study is to learn if BMS-512148 (Dapagliflozin) as part of a triple combination therapy can improve (decrease) hemoglobin A1c in patients with type 2 diabetes after 24 weeks of treatment compared to a 2 drug oral antidiabetic therapy. The safety of this treatment will also be studied.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride

Condition Name

Condition Name for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Intervention Trials
Type 2 Diabetes Mellitus 7
Type2 Diabetes Mellitus 4
Diabetes Mellitus, Type 2 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 18
Diabetes Mellitus 18
Hypoglycemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride

Trials by Country

Trials by Country for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Location Trials
United States 130
Canada 18
Mexico 17
Romania 9
United Kingdom 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Location Trials
Texas 10
California 8
Florida 8
Tennessee 6
South Carolina 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Clinical Trial Phase Trials
Phase 4 4
Phase 3 10
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Clinical Trial Phase Trials
Completed 12
Recruiting 4
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride

Sponsor Name

Sponsor Name for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Sponsor Trials
AstraZeneca 15
The University of Texas Health Science Center at San Antonio 2
the Fifth Affiliated Hospital of Zunyi Medical University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dapagliflozin; Metformin Hydrochloride; Saxagliptin Hydrochloride
Sponsor Trials
Industry 17
Other 16
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.